FDA clears CooperVision's Avaira Toric contact lenses for astigmatism

CooperVision, Inc. today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira® Toric two-week silicone hydrogel contact lenses for astigmatism. Avaira® Toric highlights CooperVision's commitment to provide eye care practitioners with a choice within the two-week modality segment for their patients. CooperVision will re-launch Avaira® Toric with shipments available for select distribution beginning early May 2012.

CooperVision's Avaira® Toric silicone hydrogel contact lenses offer patients a consistently comfortable lens wearing experience. Avaira® Toric contact lenses also have an optimized ballast design for lens stability providing patients with excellent visual acuity. The consistent fit across the power range offers eye care practitioners a great option for a wide range of astigmatic patients.

Avaira® contact lenses are designed with an innate ability to attract and retain moisture within the lens material without the need for surface treatment or wetting agents. This is thanks to AQUAFORM® Comfort Science™ which makes it the only two-week silicone hydrogel toric that is uniquely naturally wettable. This technology provides comfort that patients can rely on day after day throughout the entire wearing cycle.




The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
New project to deploy AI technology for detecting sight-threatening diabetic eye disease